Shots:
- Ambry Genetics has launched GenomeNext and GenomeReveal, a whole genome sequencing solution designed to improve diagnosis of rare diseases
- GenomeNext uses a pangenome reference to improve variant detection across diverse ancestral backgrounds, while GenomeReveal’s integrated RNA analysis provides additional evidence to help interpret certain DNA findings
- GenomeNext combines comprehensive genomic analysis, RNA evidence, and ongoing reanalysis to improve diagnostic opportunities for patients and provide updated insights
Ref: Businesswire | Image: Ambry Genetics | Press Release
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
